Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID

We present the case of a 76-year-old male patient persistently infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the setting of a stage IIIC cutaneous melanoma and non-Hodgkin’s lymphoma (NHL). Due to the persistent coronavirus disease 19 (COVID-19), all cancer treatments w...

Full description

Bibliographic Details
Main Authors: Maria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini, Gianni Gori Savellini, Chiara Terrosi, Claudia Gandolfo, Michele Maio
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Viruses
Subjects:
long COVID
monoclonal antibodies
resistance
post-exposure treatment
Online Access:https://www.mdpi.com/1999-4915/15/3/614

Internet

https://www.mdpi.com/1999-4915/15/3/614

Similar Items